Russell K. Portenoy, MD, Chairman, Department of Pain Medicine & Palliative Care at Beth Israel Medical Center in New York, discusses the appropriate positioning of opioid therapy in the treatment of pain. Opioids are now considered the primary approach to treating acute, severe pain, and the mainstay for treating chronic, moderate to severe pain.
This content was developed with Russell Portenoy, MD.
Russell Portenoy, MD has indicated the following financial disclosures during the past 12 months:
- Advisor/speaker
- Arsenal Medical Inc.
- Grupo Ferrer
- Xenon
Departmental educational/research grants
- Ameritox
- Archimedes Pharmaceuticals
- Boston Scientific
- Covidien Mallinckrodt Inc.
- Endo Pharmaceuticals
- Forest Labs
- K-Pax Pharmaceuticals
- Meda Pharmaceuticals
- Medtronics
- Otsuka Pharma
- ProStrakan
- Purdue Pharma
- Salix
- St. Jude Medical
